Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Authors:
- 28 October 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 118 (18) , 1785-1792
Abstract
Background— The benefits of statins have been demonstrated for patients with a remote history of coronary artery bypass grafting (CABG); however, no investigation to date has evaluated whether initiation of statin therapy in the early months after surgery improves clinical outcomes. Methods and Results— A retrospective cohort of 7503 Medicare patients ≥65 years of age who underwent CABG (1995–2003) was assembled by use of linked hospital and pharmacy claims data. Rates of all-cause mortality and major adverse cardiovascular events were compared between patients who were (n=1745) and were not (n=5788) prescribed statins within 1 month of CABG discharge. Additional analyses evaluated the impact of statin initiation between 1 and 6 months after surgery. Multivariable and propensity score analysis demonstrated that statin use within 1 month of CABG discharge independently reduced the risk of all-cause mortality (adjusted hazard ratio 0.82, 95% confidence interval 0.72 to 0.94) compared with no statin use. Similarly, statin use within 1 month of CABG discharge independently reduced the risk of major adverse cardiovascular events (adjusted hazard ratio 0.89, 95% confidence interval 0.81 to 0.98). Initiation of statin therapy between 1 and 6 months after CABG discharge was also associated with reductions in major adverse cardiovascular events and mortality; however, outcome rates between early (≤1 month after CABG) and delayed (1 to 6 months after CABG) statin initiation were not significantly different. Conclusions— Statin therapy initiated in the early months after hospital discharge independently reduces all-cause mortality and major adverse cardiovascular events after CABG. These findings validate the widespread practice of prescribing long-term statin therapy after CABG.Keywords
This publication has 24 references indexed in Scilit:
- Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patientsEuropean Heart Journal, 2008
- Patterns and predictors of statin use after coronary artery bypass graft surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practiceHeart, 2007
- Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: An 8-year retrospective cohort studyThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Statins Are Associated With a Reduced Incidence of Perioperative Mortality After Coronary Artery Bypass Graft SurgeryCirculation, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUO VADIS study)The American Journal of Cardiology, 2001
- Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 yearsJACC, 1996